,trial_id,completion_date_india,completion_date_global,recruitment_status_india,recruitment_status_global,publication_details,secondary_ids
0,CTRI/2020/03/024402,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
1,CTRI/2020/04/024479,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,will be published in indexed medical journal,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
2,CTRI/2020/04/024659,28/05/2020,Date Missing,Completed,Not Applicable,Sent for Publication.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Protocol No. SSV-SF-04/2020, Version 1, dated 08th Apr 2020 </td>
<td>Protocol Number </td>
</tr>]"
3,CTRI/2020/04/024706,30/05/2020,Date Missing,Completed,Not Applicable,None Yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>F.No.X.11026/74/2020-BD </td>
<td>DCGI </td>
</tr>, <tr>
<td>NCT04346446 </td>
<td>ClinicalTrials.gov </td>
</tr>]"
4,CTRI/2020/04/024731,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
5,CTRI/2020/04/024729,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
6,CTRI/2020/04/024747,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"Mouli TC, Davuluri A, Vijaya S, Priyanka AD, Mishra SK. Effectiveness of simulation based teaching of ventilatory management among non-anaesthesiology residents to manage COVID 19 pandemic - A quasi experimental cross sectional pilot study. Indian J Anaesth 2020;64:S136-40.","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
7,CTRI/2020/04/024775,Date Missing,Date Missing,Completed,Not Applicable,NA,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Protocol v 1.1 dated 12/04/20 </td>
<td>Protocol Number </td>
</tr>]"
8,CTRI/2020/04/024749,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Closed to Recruitment of Participants,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>SII-rBCG/COVID-19/IN-01, version 3.0, dated 11.04.2020 </td>
<td>Protocol Number </td>
</tr>]"
9,CTRI/2020/04/024806,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
10,CTRI/2020/04/024804,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,To be filled,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>IMD/CoV/003/2020, Version 2.1, 29 Apr 2020 </td>
<td>Protocol Number </td>
</tr>]"
11,CTRI/2020/04/024776,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
12,CTRI/2020/04/024833,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Study protocol not published. Recruitment not yet started,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
13,CTRI/2020/04/024846,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CRSC20004, Version no. 04, 07 October 2020 </td>
<td>Protocol Number </td>
</tr>]"
14,CTRI/2020/04/024857,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
15,CTRI/2020/04/024858,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
16,CTRI/2020/04/024882,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
17,CTRI/2020/04/024904,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Will be published in indexed medical journal,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
18,CTRI/2020/04/024883,24/08/2020,Date Missing,Completed,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
19,CTRI/2020/04/024915,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>MHC-COVID-19-CP, Version 2.0 dated 20-Apr-2020 </td>
<td>Protocol Number </td>
</tr>]"
20,CTRI/2020/04/024948,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
21,CTRI/2020/04/024949,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
22,CTRI/2020/04/024947,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
23,CTRI/2020/05/024967,Date Missing,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CT/MiLab/MyVir/2020   Version 1.0 dated 14th Apr 2020 </td>
<td>Protocol Number </td>
</tr>]"
24,CTRI/2020/05/024959,07/07/2020,Date Missing,Completed,Not Applicable,None Yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>ITOLI-C19-02-I-00, V3.0, 09/04/2020 </td>
<td>Protocol Number </td>
</tr>]"
25,CTRI/2020/05/024969,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
26,CTRI/2020/05/024962,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
27,CTRI/2020/05/024981,15/10/2020,Date Missing,Completed,Not Applicable,Not yet published,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>DCP-CVD-19/2020/01 Version 1.0 Dated 22nd April 2020 </td>
<td>Protocol Number </td>
</tr>]"
28,CTRI/2020/05/024983,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
29,CTRI/2020/05/024986,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None yet.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
30,CTRI/2020/05/025013,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,none,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>BIO/CT/20/000049 </td>
<td>DCGI </td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
31,CTRI/2020/05/025022,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
32,CTRI/2020/05/025067,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
33,CTRI/2020/05/025049,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
34,CTRI/2020/05/025069,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
35,CTRI/2020/05/025068,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,We will plan to publish the results of this study in reputed National and International Journals.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Not applicable </td>
<td>NIL </td>
</tr>]"
36,CTRI/2020/05/025071,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>  Not Registered in any other registry  </td>
<td>NIL </td>
</tr>]"
37,CTRI/2020/05/025088,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
38,CTRI/2020/05/025093,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>not applicable </td>
<td>NIL </td>
</tr>]"
39,CTRI/2020/05/025114,15/06/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>GPL/CT/2020/002/III, Version: 3.0, dated: 26 Apr 2020 </td>
<td>Protocol Number </td>
</tr>]"
40,CTRI/2020/05/025156,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,The trial results will be published by CCRAS at the end of clinical trial.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
41,CTRI/2020/05/025162,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
42,CTRI/2020/05/025161,15/06/2020,Date Missing,Completed,Not Applicable,Publication is under process,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>ARL/CSP/2020/002-01 </td>
<td>Protocol Number </td>
</tr>]"
43,CTRI/2020/05/025166,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>not applicable </td>
<td>NIL </td>
</tr>]"
44,CTRI/2020/05/025178,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
45,CTRI/2020/05/025167,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,None yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>0248-20, Version No: 3.0, Date : 07 july 2020 </td>
<td>Protocol Number </td>
</tr>]"
46,CTRI/2020/05/025171,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
47,CTRI/2020/05/025213,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"Outcomes of the study will be published in the reputed journal of the council, Journal of Research in Ayurvedic Sciences JRAS","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
48,CTRI/2020/05/025205,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None yet.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
49,CTRI/2020/05/025214,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
50,CTRI/2020/05/025209,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NA,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
51,CTRI/2020/05/025215,15/06/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
52,CTRI/2020/05/025222,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
53,CTRI/2020/05/025224,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Results will be published in relevant open access peer-reviewed scientific journals.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
54,CTRI/2020/05/025242,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"After data analysis , study will publish.","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>83341 </td>
<td>Protocol Number </td>
</tr>]"
55,CTRI/2020/05/025272,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,This study will be published in an indexed journal,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
56,CTRI/2020/05/025254,14/08/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CCRUM 05/2020/01 Version 1.0 </td>
<td>Protocol Number </td>
</tr>]"
57,CTRI/2020/05/025276,17/06/2020,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
58,CTRI/2020/05/025273,14/06/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
59,CTRI/2020/05/025275,21/09/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
60,CTRI/2020/05/025271,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CRSC20006, version no. 02, 15.04.2020 </td>
<td>Protocol Number </td>
</tr>]"
61,CTRI/2020/05/025248,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
62,CTRI/2020/05/025277,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CRSC20005, version no. 02, 15.04.2020 </td>
<td>Protocol Number </td>
</tr>]"
63,CTRI/2020/05/025299,28/08/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>WH-CP-02-21;Amendment 02;26 Apr 2020 </td>
<td>Protocol Number </td>
</tr>]"
64,CTRI/2020/05/025298,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
65,CTRI/2020/05/025320,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
66,CTRI/2020/05/025317,09/07/2020,Date Missing,Completed,Not Applicable,The study results will be published in an appropriate journal,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
67,CTRI/2020/05/025319,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
68,CTRI/2020/05/025331,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
69,CTRI/2020/05/025326,17/09/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
70,CTRI/2020/05/025328,Date Missing,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Protocol No. Covid 19, Version no 1.1, Dated 11 May 2020 </td>
<td>Protocol Number </td>
</tr>]"
71,CTRI/2020/05/025338,01/09/2020,Date Missing,Completed,Not Applicable,Under Process,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NA </td>
<td>NIL </td>
</tr>]"
72,CTRI/2020/05/025336,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
73,CTRI/2020/05/025334,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
74,CTRI/2020/05/025337,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
75,CTRI/2020/05/025335,11/08/2020,Date Missing,Completed,Not Applicable,Under process.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
76,CTRI/2020/05/025341,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,no,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
77,CTRI/2020/05/025343,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
78,CTRI/2020/05/025346,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,not yet.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Form CT-06, No. CT/BP/07/2020  </td>
<td>DCGI </td>
</tr>]"
79,CTRI/2020/05/025350,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Results will be published in relevant open access peer-reviewed scientific journals.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
80,CTRI/2020/05/025370,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
81,CTRI/2020/05/025385,17/08/2020,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Nil </td>
<td>NIL </td>
</tr>]"
82,CTRI/2020/05/025369,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>TCZ/COVID-19/01/2020 Version 2.0 dated 05 May 2020 </td>
<td>Protocol Number </td>
</tr>]"
83,CTRI/2020/05/025425,18/08/2020,Date Missing,Completed,Not Applicable,Under Process,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
84,CTRI/2020/05/025398,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>No </td>
<td>NIL </td>
</tr>]"
85,CTRI/2020/05/025397,19/08/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>ICR/20/005; Version No. 1.0; Dated 01/MAY/2020 </td>
<td>Protocol Number </td>
</tr>]"
86,CTRI/2020/05/025429,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,"6.	Acharya YT, editor. Charaka Samhita (Ch. Chi. 3/). Varanasi: Chowkhamba Surbharati; 2000
7.	Peruski, A. H., & Peruski, L. F., Jr (2003). Immunological methods for detection and identification of infectious disease and biological warfare agents. Clinical and diagnostic laboratory immunology, 10(4), 506–513. https://doi.org/10.1128/cdli.10.4.506-513.2003
8.	KamWa Chan, Vivian Taam Wong, and Sydney Chi Wai Tang, COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese–Western Medicine for the Management of 2019 Novel Coronavirus Disease, The American Journal of Chinese Medicine, Vol. 48, No. 3, 1–26 , Published 13 March 2020, DOI: 10.1142/S0192415X20500378","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
87,CTRI/2020/05/025434,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,No publications done so far,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
88,CTRI/2020/05/025483,30/06/2020,Date Missing,Completed,Not Applicable,Under publication process,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
89,CTRI/2020/05/025485,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
90,CTRI/2020/05/025484,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
91,CTRI/2020/05/025490,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>U1111-1252-7438 </td>
<td>UTN </td>
</tr>]"
92,CTRI/2020/05/025488,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NOT YET DONE,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIA-CVD-19/2020/01 Version 1.0 Dated 20th May 2020 </td>
<td>Protocol Number </td>
</tr>]"
93,CTRI/2020/05/025491,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Nil </td>
<td>NIL </td>
</tr>]"
94,CTRI/2020/05/025489,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NA,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
95,CTRI/2020/05/025492,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Not registered in other registries </td>
<td>NIL </td>
</tr>]"
96,CTRI/2020/05/025496,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
97,CTRI/2020/06/025523,21/08/2020,Date Missing,Completed,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
98,CTRI/2020/06/025522,Date Missing,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
99,CTRI/2020/06/025527,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Closed to Recruitment of Participants,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CT/Vopec/Amrta Karuna /2020 version 1.0 dated 24th Apr 2020 </td>
<td>Protocol Number </td>
</tr>]"
100,CTRI/2020/06/025557,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>AYUSH-CSIR-TRT-01 </td>
<td>Protocol Number </td>
</tr>]"
101,CTRI/2020/06/025530,28/10/2020,Date Missing,Completed,Not Applicable,To be published in the Annual Report of Cancer Aid Society,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
102,CTRI/2020/06/025556,21/08/2020,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>PHAR/CT/VIRULINA/COVID/10052020 Version 01 dated 11 May 2020 </td>
<td>Protocol Number </td>
</tr>]"
103,CTRI/2020/06/025558,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Publication of Results in a Peer-reviewed scientific journal or presentation at a scientific Congress.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
104,CTRI/2020/06/025575,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Open to Recruitment,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
105,CTRI/2020/06/025590,28/09/2020,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>DAL/CT/001/AST/2020 Version No. 1.0, dated 23rd April 2020 </td>
<td>Protocol Number </td>
</tr>]"
106,CTRI/2020/06/025589,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>not applicable </td>
<td>ClinicalTrials.gov </td>
</tr>]"
107,CTRI/2020/06/025613,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
108,CTRI/2020/06/025637,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
109,CTRI/2020/06/025625,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
110,CTRI/2020/06/025664,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CVD-19-CD-002, Version 5.0, 22 July 2020 </td>
<td>Protocol Number </td>
</tr>]"
111,CTRI/2020/06/025650,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"The recorded data, after analysis, may be published by sponsor or with the investigators consent in peer reviewed scientific journals without revealing the identity of any subject.","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
112,CTRI/2020/06/025672,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"The recorded data, after analysis, may be published by sponsor or with the investigators consent in peer reviewed scientific journals without revealing the identity of any subject.","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
113,CTRI/2020/06/025671,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
114,CTRI/2020/06/025702,Date Missing,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Protocol Version 1.0 Dated 9th Apr 2020 </td>
<td>Protocol Number </td>
</tr>]"
115,CTRI/2020/06/025704,07/11/2020,Date Missing,Completed,Not Applicable,NIL.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>BSV_ULINA_20_03_IN  ver 02/19-May-2020 </td>
<td>Protocol Number </td>
</tr>]"
116,CTRI/2020/06/025714,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not Applicable,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
117,CTRI/2020/06/025763,Date Missing,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
118,CTRI/2020/06/025766,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"https://pubmed.ncbi.nlm.nih.gov/29732571/
https://pubmed.ncbi.nlm.nih.gov/31930543/","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
119,CTRI/2020/06/025760,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil at present,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
120,CTRI/2020/06/025768,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
121,CTRI/2020/06/025762,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
122,CTRI/2020/06/025769,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
123,CTRI/2020/06/025801,25/08/2020,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>HDC/CP/PP/037/2020 Version 1.0 Dated 07 May 2020  </td>
<td>Protocol Number </td>
</tr>]"
124,CTRI/2020/06/025796,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
125,CTRI/2020/06/025798,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
126,CTRI/2020/06/025779,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
127,CTRI/2020/06/025799,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CP/04/20, Version No. 1.0, dated 02/May/2020 </td>
<td>Protocol Number </td>
</tr>]"
128,CTRI/2020/06/025800,30/06/2020,Date Missing,Completed,Closed to Recruitment of Participants,The outcome of the Study will be published in International peer reviewed Journal.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
129,CTRI/2020/06/025804,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
130,CTRI/2020/06/025803,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,None Yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>COPLA Trial-II/ILBS/2020 dated 24.05.2020 </td>
<td>NIL </td>
</tr>]"
131,CTRI/2020/06/025849,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CVD-19-CD-001; Version 4.0; 14 July 2020  </td>
<td>Protocol Number </td>
</tr>]"
132,CTRI/2020/06/025852,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,none,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
133,CTRI/2020/06/025844,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None yet.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
134,CTRI/2020/06/025854,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Version 3.2, 17/05/2020 </td>
<td>Protocol Number </td>
</tr>]"
135,CTRI/2020/06/025856,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
136,CTRI/2020/06/025855,13/08/2020,Date Missing,Completed,Not Applicable,not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
137,CTRI/2020/06/025861,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
138,CTRI/2020/06/025862,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>LDRT-Covid-19 </td>
<td>Other </td>
</tr>]"
139,CTRI/2020/06/025874,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
140,CTRI/2020/06/025927,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nill,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
141,CTRI/2020/06/025928,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
142,CTRI/2020/06/025917,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None so far,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
143,CTRI/2020/06/025957,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>GPL/CT/2020/004/III, Version:4.0, Dated:03-Jun-2020 </td>
<td>Protocol Number </td>
</tr>]"
144,CTRI/2020/06/025977,28/11/2020,Date Missing,Completed,Not Applicable,No any publication planned yet.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>ARL/CSP/2020/003-00, Ver 00, Dt 01-06-2020 </td>
<td>Protocol Number </td>
</tr>]"
145,CTRI/2020/06/025996,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Closed to Recruitment of Participants,Not Applicable,Not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
146,CTRI/2020/06/025998,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"1. Raj kumar, Ramakant Yadav, Ramakant Rawat, Prashant Kumar Bajpai, Indra Kumar Sharma, Sushil Kumar, Prashant Yadav. Role of Raj Nirvan Bati in treatment of COVID19 RT-PCR positive cases. IJSRM June 2020; Accepted for publication
2. 1. Raj kumar, Ramakant Yadav, Ramakant Rawat, Prashant Kumar Bajpai, Indra Kumar Sharma, Sushil Kumar, Prashant Yadav. Raj Nirvan Bati (A novel ayurvedic preparation) in RT PCR positive COVID19 cases: An interventional study. IJMSCR June 2020;3(3)","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
147,CTRI/2020/06/026001,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
148,CTRI/2020/06/025999,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>MHC/CT/20-21/003 Ver. 2.0 dated, Dated 3rd June 2020 </td>
<td>Protocol Number </td>
</tr>]"
149,CTRI/2020/06/026002,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
150,CTRI/2020/06/026045,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"The manuscript of the trial will be prepared

Research publication will be done in indexed peer reviewed journal","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
151,CTRI/2020/06/026055,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
152,CTRI/2020/06/026056,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
153,CTRI/2020/06/026087,04/09/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>PEGI.20.002,Version 3.12May2020 </td>
<td>Protocol Number </td>
</tr>]"
154,CTRI/2020/06/026123,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
155,CTRI/2020/06/026119,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not Yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
156,CTRI/2020/06/026147,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NILL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
157,CTRI/2020/06/026151,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,not yet published,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
158,CTRI/2020/06/026161,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>COVID 19/AYUSH-ICMR 2020/Adjunct Protocol-AF-II </td>
<td>Protocol Number </td>
</tr>]"
159,CTRI/2020/06/026181,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CT/AZADVIR /2020 Version 1.0 dated 01 June 2020 </td>
<td>Protocol Number </td>
</tr>]"
160,CTRI/2020/06/026190,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
161,CTRI/2020/06/026187,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>PROTOCOL NO- MHC/CT/20-21/002  Ver. 2.0, Dated 3rd June 2020 </td>
<td>Protocol Number </td>
</tr>]"
162,CTRI/2020/06/026189,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
163,CTRI/2020/06/026191,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>MUR/01/2020 </td>
<td>NIL </td>
</tr>]"
164,CTRI/2020/06/026192,30/09/2020,30/09/2020,Completed,Completed,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>2020-001502-38 </td>
<td>EudraCT </td>
</tr>, <tr>
<td>VP-C21-006 Version 1.0 dated 24-Apr-2020 </td>
<td>Protocol Number </td>
</tr>]"
165,CTRI/2020/06/026195,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None yet.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
166,CTRI/2020/06/026196,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Yet Recruiting,No Publications yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>2020-001448-24 </td>
<td>EudraCT </td>
</tr>]"
167,CTRI/2020/06/026193,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
168,CTRI/2020/06/026197,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
169,CTRI/2020/06/026228,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Open to Recruitment,Not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>ACE-ID-201 (D822FC00001) Version 3.0 dated. 28/04/2020 </td>
<td>Protocol Number </td>
</tr>]"
170,CTRI/2020/06/026222,12/09/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>VB-N-IVIG-COVID-19/2020-CT2; version 2 date 20.05.2020 </td>
<td>Protocol Number </td>
</tr>]"
171,CTRI/2020/06/026227,27/07/2020,Date Missing,Completed,Not Applicable,Not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CCRUM 04/06/2020/ Version 1.0/ 10/06/20 </td>
<td>Protocol Number </td>
</tr>]"
172,CTRI/2020/06/026229,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
173,CTRI/2020/06/026220,05/09/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>ICR/20/004, Version No. 1.0; Dated 23/APR/2020 </td>
<td>Protocol Number </td>
</tr>]"
174,CTRI/2020/06/026232,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
175,CTRI/2020/06/026231,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
176,CTRI/2020/06/026221,10/08/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
177,CTRI/2020/06/026262,29/10/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
178,CTRI/2020/07/026301,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
179,CTRI/2020/07/026337,31/08/2020,31/08/2020,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
180,CTRI/2020/07/026338,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
181,CTRI/2020/07/026340,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
182,CTRI/2020/07/026343,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>AR/RC/T-01 </td>
<td>Protocol Number </td>
</tr>, <tr>
<td>Therapautic Study  </td>
<td>NIL </td>
</tr>]"
183,CTRI/2020/07/026349,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
184,CTRI/2020/07/026355,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
185,CTRI/2020/07/026354,04/09/2020,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>MHC/CT/20-21/005 Version 1.0 dated, 15th June 2020 </td>
<td>Protocol Number </td>
</tr>]"
186,CTRI/2020/07/026353,31/07/2020,Date Missing,Completed,Not Applicable,Not yet done,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
187,CTRI/2020/07/026352,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Closed to Recruitment of Participants,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NCOV 1002 Version 02 dated 02 July 2020 </td>
<td>Protocol Number </td>
</tr>]"
188,CTRI/2020/07/026371,Date Missing,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
189,CTRI/2020/07/026431,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,[]
190,CTRI/2020/07/026433,09/10/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
191,CTRI/2020/07/026463,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
192,CTRI/2020/07/026462,12/09/2020,Date Missing,Completed,Not Applicable,Not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
193,CTRI/2020/07/026471,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
194,CTRI/2020/07/026469,18/07/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
195,CTRI/2020/07/026468,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>COVID 19/AYUSH-ICMR 2020/Adjunct Protocol-AF-III </td>
<td>Protocol Number </td>
</tr>]"
196,CTRI/2020/07/026470,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
197,CTRI/2020/07/026514,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
198,CTRI/2020/07/026515,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
199,CTRI/2020/07/026532,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Nil </td>
<td>NIL </td>
</tr>]"
200,CTRI/2020/07/026534,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
201,CTRI/2020/07/026529,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Will be published in Pubmed indexed journal,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
202,CTRI/2020/07/026528,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
203,CTRI/2020/07/026530,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
204,CTRI/2020/07/026535,31/08/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
205,CTRI/2020/07/026560,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Closed to Recruitment of Participants,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CTP/NB/03/20, Version 1 dated 18 April 2020 </td>
<td>Protocol Number </td>
</tr>]"
206,CTRI/2020/07/026575,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
207,CTRI/2020/07/026570,03/09/2020,Date Missing,Completed,Not Applicable,"Protocol got published in BioMed Central, on 23 Nov 2020. Results are yet to be published","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
208,CTRI/2020/07/026579,07/09/2020,Date Missing,Completed,Not Applicable,1)Evaluation of the Clinical Efficacy and safety of IM-133N as an Immunomodulator in various carcinoma :A prospective Clinical Study 2)A Clinical Analysis of Evaluating the Usefulness and Efficacy of the Ayurvedic Drug Tinospora cordifolia in Humans,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>HDC/CP/PP/036/2020 Version 1.0 Dated 07 May 2020   </td>
<td>Protocol Number </td>
</tr>]"
209,CTRI/2020/07/026568,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
210,CTRI/2020/07/026602,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Will be published in PubMed indexed journal.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
211,CTRI/2020/07/026608,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
212,CTRI/2020/07/026609,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
213,CTRI/2020/07/026607,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,will be published in high impact journals,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
214,CTRI/2020/07/026601,23/08/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
215,CTRI/2020/07/026630,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>MHC/CTH/20-21/002 Ver. 2.0, Dated 03rd June 2020 </td>
<td>Protocol Number </td>
</tr>]"
216,CTRI/2020/07/026632,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
217,CTRI/2020/07/026631,03/09/2020,Date Missing,Completed,Not Applicable,uses of herbal powder in hot water taken after meals by oral route in covid 19 positive patients to improve their spo2 levels. It acts as a immunity booster .,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
218,CTRI/2020/07/026667,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NA,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
219,CTRI/2020/07/026669,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
220,CTRI/2020/07/026673,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not Applcaple,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
221,CTRI/2020/07/026668,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
222,CTRI/2020/07/026670,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
223,CTRI/2020/07/026671,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
224,CTRI/2020/07/026674,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
225,CTRI/2020/07/026675,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
226,CTRI/2020/07/026705,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,not applicable as study not started yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
227,CTRI/2020/07/026700,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
228,CTRI/2020/07/026757,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
229,CTRI/2020/07/026756,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
230,CTRI/2020/07/026791,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
231,CTRI/2020/07/026796,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
232,CTRI/2020/07/026789,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>MGC-006 Version 03 dated 14 May 2020 </td>
<td>Protocol Number </td>
</tr>]"
233,CTRI/2020/07/026790,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
234,CTRI/2020/07/026799,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
235,CTRI/2020/07/026793,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>MHC/CT/20-21/010 Version 1.0 dated, 5th July 2020 </td>
<td>Protocol Number </td>
</tr>]"
236,CTRI/2020/07/026831,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"The study will be conducted in the name of the ‘CLARITY Study Investigators’. Central project coordination and data management will be provided by The George Institute for Global Health, Delhi, India. Authorship of publications arising from the study will be the management committee with full credit assigned to all collaborating Institutions, investigators and site research staff. Responsibility for the content of manuscripts will rest with the writing committee, and, where listed, the chair of the writing committee will be listed first with subsequent members listed alphabetically. It is expected that findings will be disseminated via publication in high-quality peer reviewed journals in the medical literature. Study findings will also be presented at regional, national, international intensive care conferences, and results via social media and mainstream media platforms.","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
237,CTRI/2020/07/026820,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,no,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
238,CTRI/2020/07/026834,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
239,CTRI/2020/07/026840,11/09/2020,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
240,CTRI/2020/07/026839,23/09/2020,Date Missing,Completed,Not Applicable,Publication which arise directly out of this trial results,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>SSV-SF-07/2020, Version 1, dated 20th Jul 2020 </td>
<td>Protocol Number </td>
</tr>]"
241,CTRI/2020/07/026835,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
242,CTRI/2020/07/026841,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None yet.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
243,CTRI/2020/07/026925,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
244,CTRI/2020/07/026922,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,the outcome of this study shall be published in a peer reviewed national or international journa.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
245,CTRI/2020/07/026953,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
246,CTRI/2020/07/026952,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
247,CTRI/2020/08/026957,01/12/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>MGCTS/20/105 VERSION: 01 DATED 08 JUN 2020 </td>
<td>Protocol Number </td>
</tr>]"
248,CTRI/2020/08/026980,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
249,CTRI/2020/08/026977,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,[]
250,CTRI/2020/08/026985,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
251,CTRI/2020/08/026978,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Applicable,Not Yet Recruiting,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
252,CTRI/2020/08/027007,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nill,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
253,CTRI/2020/08/026999,08/11/2020,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
254,CTRI/2020/08/027005,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,None,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
255,CTRI/2020/08/027009,Date Missing,Date Missing,Completed,Not Applicable,Not yet finalised on the journal in which the data from the current study would be published.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
256,CTRI/2020/08/027033,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"Not Yet published, Publication is after completion of the study","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
257,CTRI/2020/08/027032,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,To be filled,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>TG/PRO/CLI/034 Version 1.0 dated 10 July 2020 </td>
<td>Protocol Number </td>
</tr>]"
258,CTRI/2020/08/027038,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
259,CTRI/2020/08/027035,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
260,CTRI/2020/08/027037,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
261,CTRI/2020/08/027040,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
262,CTRI/2020/08/027048,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
263,CTRI/2020/08/027045,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Will publish the data in peer reviewed journal after completion of the study and analysis,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Version 1.1 dated 29 July 2020 </td>
<td>Protocol Number </td>
</tr>]"
264,CTRI/2020/08/027043,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CT-06/2020 </td>
<td>DCGI </td>
</tr>]"
265,CTRI/2020/08/027041,Date Missing,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Herbovir/CT/2020 Version 1.0 Dated 15th July 2020 </td>
<td>Protocol Number </td>
</tr>]"
266,CTRI/2020/08/027044,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
267,CTRI/2020/08/027084,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>U1111 - 1256 - 7669 </td>
<td>UTN </td>
</tr>]"
268,CTRI/2020/08/027061,01/11/2020,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>IITTHY00120,Version 01 dated 28 Jun 2020 </td>
<td>Protocol Number </td>
</tr>]"
269,CTRI/2020/08/027080,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
270,CTRI/2020/08/027081,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
271,CTRI/2020/08/027085,10/09/2020,Date Missing,Completed,Not Applicable,none yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
272,CTRI/2020/08/027102,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
273,CTRI/2020/08/027106,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NOT YET,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
274,CTRI/2020/08/027120,24/11/2020,Date Missing,Completed,Not Applicable,"Rajesh Biswas, Kakoli Biswas, Parikshit Bansal and Shashi Gupta; ANTI-VIRAL (ANTI-FLU), ANTI-BACTERIAL IMMUNOBOOSTING ORAL COMPOSITION OF HERBAL EXTRACTS FOR TREATING RESPIRATORY INFECTIONS – A CASE STUDY; ejpmr, 2020,7(6), 760-765.","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>PHAR/CT/Virowin/14072020/01; VERSION 01 DATED 14 July, 2020 </td>
<td>Protocol Number </td>
</tr>]"
275,CTRI/2020/08/027163,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>AYUSH- CRD-HCW-01, version number 1.1, dated 01 Aug 2020 </td>
<td>Protocol Number </td>
</tr>]"
276,CTRI/2020/08/027162,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Closed to Recruitment of Participants,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>TML/IAD/2020/01 Version 1.1 24 Jul 2020 </td>
<td>Protocol Number </td>
</tr>]"
277,CTRI/2020/08/027168,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>PROCLIN_COVID-005 ver.1.0 date 09 July 2020 </td>
<td>Protocol Number </td>
</tr>]"
278,CTRI/2020/08/027170,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Closed to Recruitment of Participants,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>ICMR/SII-COVISHIELD Version 4.0 dated 14 Oct 2020 </td>
<td>Protocol Number </td>
</tr>]"
279,CTRI/2020/08/027171,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not Yet Published,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
280,CTRI/2020/08/027224,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
281,CTRI/2020/08/027225,Date Missing,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
282,CTRI/2020/08/027222,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
283,CTRI/2020/08/027282,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"1.	Şimşek Yavuz S, Ünal S. Antiviral treatment of COVID-19. Turk J
Med Sci. 2020;50(SI-1):611-619. Published 2020 Apr 21.
doi:10.3906/sag-2004-145.
2.	Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDAapproved
drug ivermectin inhibits the replication of SARS-CoV-2
in vitro. Antiviral Res. 2020. https://doi.org/
10.1016/j.antiviral.2020.104787
3.	 Patrì A, Fabbrocini G. Hydroxychloroquine and ivermectin: A
synergistic combination for COVID-19 chemoprophylaxis and
treatment?. J Am Acad Dermatol. 2020;82(6):e221.
doi:10.1016/j.jaad.2020.04.017.","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
284,CTRI/2020/08/027284,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>TG/PRO/CLI/035 Version 2.0 dated 14 Aug 2020 </td>
<td>Protocol Number </td>
</tr>]"
285,CTRI/2020/08/027283,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
286,CTRI/2020/08/027316,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
287,CTRI/2020/08/027286,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
288,CTRI/2020/08/027300,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
289,CTRI/2020/08/027324,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
290,CTRI/2020/08/027345,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
291,CTRI/2020/08/027346,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
292,CTRI/2020/08/027359,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"1. 	Arshad MS, Khan U, Sadiq A, Khalid W, Hussain M, Yasmeen A, et al. Coronavirus disease (COVID-19) and immunity booster green foods: A mini review. Food Sci Nutr. 2020;(June). 
2. 	AYUSH M of. Ayurveda’s immunity boosting measures for self care during COVID 19 crisis. 2020;1(1):4. 
3. 	Ministry of AYUSH RK. ADVISORY FROM MINISTRY OF AYUSH FOR MEETING THE CHALLENGE ARISING OUT OF SPREAD OF CORONA VIRUS (COVID-19) IN INDIA. 2020;9–12. 
4. 	Abascal K, Yarnell E. Herbal treatments for pandemic influenza: Learning from the eclectics’ experience. Altern Complement Ther. 2006;12(5):214–21. 
5.       Ravi Philip Rajkumar. Ayurveda and COVID-19: Where psychoneuroimmunology and the meaning   response meet.  Brain Behav Immun. 2020 Jul; 87: 8–9. Published online 2020 Apr 22.
6. 	AYUSH, ministy of N. GUIDELINES for NATUROPATHY PRACTITIONERS for COVID 19. 2020;","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
293,CTRI/2020/08/027394,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,publication after study is completed,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
294,CTRI/2020/08/027397,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
295,CTRI/2020/08/027465,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,None,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
296,CTRI/2020/08/027501,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Closed to Recruitment of Participants,Not Applicable,none,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>BIAG-CSP-037 Version Number: 1.0   Date: 20 May 2020   </td>
<td>Protocol Number </td>
</tr>]"
297,CTRI/2020/08/027475,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
298,CTRI/2020/08/027502,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
299,CTRI/2020/08/027477,08/10/2020,Date Missing,Completed,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
300,CTRI/2020/08/027499,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
301,CTRI/2020/08/027491,20/10/2020,20/10/2020,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
302,CTRI/2020/08/027503,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
303,CTRI/2020/08/027467,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
304,CTRI/2020/09/027535,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CDRI-CLINICAL2/2020 version 2 dated 4th June 2020 </td>
<td>Protocol Number </td>
</tr>, <tr>
<td>U1111-1251-8421 </td>
<td>UTN </td>
</tr>]"
305,CTRI/2020/09/027548,21/10/2020,Date Missing,Completed,Not Applicable,none yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
306,CTRI/2020/09/027616,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
307,CTRI/2020/09/027615,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,none yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>1.0 </td>
<td>Protocol Number </td>
</tr>]"
308,CTRI/2020/09/027622,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Nil </td>
<td>NIL </td>
</tr>]"
309,CTRI/2020/09/027661,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
310,CTRI/2020/09/027674,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Not applicable,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>BBIL/BBV152D-B/2020 Version: 3.0; Dated: 17/08/2020 </td>
<td>Protocol Number </td>
</tr>]"
311,CTRI/2020/09/027684,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
312,CTRI/2020/09/027687,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"Satomura K, Kitamura T, Kawamura T, Shimbo T, Watanabe M, Kamei M, et al. Prevention of Upper Respiratory Tract Infections by Gargling A Randomized Trial. American Journal of Preventive Medicine. 2005 Nov;29(4):302–7. 

12.Ananthanarayan R, Paniker Jayaram CK. Ananthanarayans and Panikers textbook of microbiology.7th ed. Hyderabad: Orient Longman Private Limited; 2005. p.434","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
313,CTRI/2020/09/027685,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>PROCLIN_COVID-005_Version 1 Dated 09 July 2020 </td>
<td>Protocol Number </td>
</tr>]"
314,CTRI/2020/09/027741,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
315,CTRI/2020/09/027775,06/12/2020,Date Missing,Completed,Not Applicable,None yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
316,CTRI/2020/09/027786,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
317,CTRI/2020/09/027817,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
318,CTRI/2020/09/027841,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CPL/90/IMM_COVD/I/AUG/20,V1.0,29-AUG-20 </td>
<td>Protocol Number </td>
</tr>]"
319,CTRI/2020/09/027829,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Open to Recruitment,"Together with the Sponsor, the Executive Committee will be responsible for the final overall study design, including the development of the study protocol and eCRF, supervision of the study conduct and progress, development of any protocol amendments needed during the study, liaison with the IDSMC as needed, development of the SAP, interpretation of the final data and reporting (presentations at international congresses and publications in peer reviewed journals) of the study. The Executive Committee will make recommendations to Saint Luke’s Hospital of Kansas City with regard to early stopping or modifications of the study based on the information received from the IDSMC.
The Executive Committee will be comprised of the overall study PI (Chair), designated international academic leaders, and non-voting members of AstraZeneca, and will operate under an Executive Committee Charter.","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>D1690C00081 Version 3.0 Date 20 May 2020 </td>
<td>Protocol Number </td>
</tr>]"
320,CTRI/2020/09/027842,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
321,CTRI/2020/09/027833,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>CIMED-002-2020 Version1.1, 15 Aug 2020 </td>
<td>Protocol Number </td>
</tr>, <tr>
<td>NCT04512027 </td>
<td>ClinicalTrials.gov </td>
</tr>]"
322,CTRI/2020/09/027882,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
323,CTRI/2020/09/027904,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
324,CTRI/2020/09/027903,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,None (yet),"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>0279-20, Version 2.0, Dated: 28-Aug-2020 </td>
<td>Protocol Number </td>
</tr>]"
325,CTRI/2020/09/027910,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
326,CTRI/2020/09/027914,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
327,CTRI/2020/09/027915,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
328,CTRI/2020/09/027941,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None Yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td> ITOLI-C19-04-I-01,  Version 2.0, Dated 05-August-2020  </td>
<td>Protocol Number </td>
</tr>]"
329,CTRI/2020/09/027938,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Publication which arise directly out of this trial results,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>PLS-SF-09/2020, Version 1, dated 01st Sep 2020 </td>
<td>Protocol Number </td>
</tr>]"
330,CTRI/2020/09/027916,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
331,CTRI/2020/09/027974,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
332,CTRI/2020/09/027944,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
333,CTRI/2020/09/027975,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Interim analysis shall be done after study completion of at least 25% of participants And final analysis will be after study.results will be published in journals,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
334,CTRI/2020/09/027992,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>IIT_THY_002_20,Version 01 dated 01 July 2020 </td>
<td>Protocol Number </td>
</tr>]"
335,CTRI/2020/09/028045,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
336,CTRI/2020/09/028044,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>ARTI/WBPL/P4/2020/01 Version 1.1 dated 25 Aug 2020 </td>
<td>Protocol Number </td>
</tr>]"
337,CTRI/2020/09/028043,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
338,CTRI/2020/09/028046,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Other (Terminated),Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
339,CTRI/2020/09/028086,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
340,CTRI/2020/09/028088,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
341,CTRI/2020/09/028131,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td> Cordyceps-2001, Version 1, 20 August 2020 </td>
<td>Protocol Number </td>
</tr>]"
342,CTRI/2020/09/028122,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
343,CTRI/2020/09/028133,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
344,CTRI/2020/09/028158,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,It is anticipated that the results of this study may be presented at scientific meetings and/or published in a peer reviewed scientific or medical journal. Current guidelines and recommendations on good publication practice will be followed,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
345,CTRI/2020/09/028164,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
346,CTRI/2020/10/028195,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
347,CTRI/2020/10/028179,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Applicable,Open to Recruitment,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
348,CTRI/2020/10/028230,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
349,CTRI/2020/10/028233,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
350,CTRI/2020/10/028231,01/12/2020,Date Missing,Completed,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>BPLS/KTJ/2020 Version 1.0 Dated 31 July 2020 </td>
<td>Protocol Number </td>
</tr>]"
351,CTRI/2020/10/028234,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,no,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
352,CTRI/2020/10/028253,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
353,CTRI/2020/10/028256,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
354,CTRI/2020/10/028250,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>ICMR/ARDS/20-21/001 ver 3 dated 25.06.2020 </td>
<td>Protocol Number </td>
</tr>]"
355,CTRI/2020/10/028280,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
356,CTRI/2020/10/028277,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>GB_THY_001_20 Version 02 dated 24 Aug 2020 </td>
<td>Protocol Number </td>
</tr>]"
357,CTRI/2020/10/028279,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
358,CTRI/2020/10/028297,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>U1111-1259-2654 </td>
<td>UTN </td>
</tr>]"
359,CTRI/2020/10/028333,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,No,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
360,CTRI/2020/10/028335,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,none yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Tinefcon/01/20 Final dated 30 June 2020 </td>
<td>Protocol Number </td>
</tr>]"
361,CTRI/2020/10/028324,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
362,CTRI/2020/10/028326,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NA,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NKPROTOCOL0401 Version 01 Date: 06/05/2020 </td>
<td>Protocol Number </td>
</tr>]"
363,CTRI/2020/10/028325,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
364,CTRI/2020/10/028364,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>EPRD0202-010920_V1R1_28.09.2020 </td>
<td>Protocol Number </td>
</tr>]"
365,CTRI/2020/10/028362,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NONE YET,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>JRH/IEC/2020/COVID19/Pranayama breathing technique </td>
<td>Protocol Number </td>
</tr>]"
366,CTRI/2020/10/028376,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"""None Yet""","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
367,CTRI/2020/10/028414,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
368,CTRI/2020/10/028423,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>BCR-PNB-001 version 4.0 dated 02 Sep 2020 </td>
<td>Protocol Number </td>
</tr>, <tr>
<td>CT/ND/95/2020 </td>
<td>DCGI </td>
</tr>]"
369,CTRI/2020/10/028424,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
370,CTRI/2020/10/028437,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
371,CTRI/2020/10/028472,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
372,CTRI/2020/10/028471,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,none yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
373,CTRI/2020/10/028486,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
374,CTRI/2020/10/028485,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not Yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
375,CTRI/2020/10/028568,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not Published,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>MHC/CT/20-21/007  </td>
<td>Protocol Number </td>
</tr>]"
376,CTRI/2020/10/028566,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not Yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
377,CTRI/2020/10/028537,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>MHC/CT/20-21/011, Version 1, Dated 08 Sept 2020 </td>
<td>Protocol Number </td>
</tr>]"
378,CTRI/2020/10/028570,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
379,CTRI/2020/10/028597,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
380,CTRI/2020/10/028602,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Open to Recruitment,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>BGBC020 dated 08-Oct-2020 </td>
<td>Protocol Number </td>
</tr>]"
381,CTRI/2020/10/028581,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
382,CTRI/2020/10/028580,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,No Publications yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
383,CTRI/2020/10/028637,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,trial will started after the ctri registration,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
384,CTRI/2020/10/028635,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
385,CTRI/2020/10/028695,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
386,CTRI/2020/10/028731,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Yet Recruiting,"The trial results will be communicated to all site investigators by teleconference prior to publication or presentation. The trial results will also be submitted for presentation at national and international meetings and publications submitted to a peer reviewed scientific journal, irrespective of the results. A plain-language summary of the trial results will be made available to individual participants upon request. Primary and senior authorship will be determined by the study steering committee. Hospitals contributing at least one case for analysis will nominate a locally determined coordinating investigator for inclusion, in order of number of participants enrolled.","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NCT04509973 </td>
<td>ClinicalTrials.gov </td>
</tr>]"
387,CTRI/2020/11/028799,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Nil </td>
<td>NIL </td>
</tr>]"
388,CTRI/2020/11/028811,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Results of study to be published in a peer review in Index journal.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
389,CTRI/2020/11/028779,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>BECT063/Equine.CoV.Ab-Phase-I/CTP-01Ver: 1.1 dated:07.10.20  </td>
<td>Protocol Number </td>
</tr>]"
390,CTRI/2020/11/028827,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
391,CTRI/2020/11/028905,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
392,CTRI/2020/11/028903,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None Yet.,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
393,CTRI/2020/11/028897,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,"The results of this study are planned to be published in order to provide information on efficacy
and safety of ANT-V Syrup in management of upper respiratory tract infections, in Indian population","[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
394,CTRI/2020/11/028959,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
395,CTRI/2020/11/028976,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>BBIL/BBV152-C/2020 Version No: 3.0; Date: 20-10-2020 </td>
<td>Protocol Number </td>
</tr>]"
396,CTRI/2020/11/029025,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
397,CTRI/2020/11/029032,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,None,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>BECT062/Covid-19-phase-I&amp;II/CTP-01Ver: 1.1 dated:07.10.20 </td>
<td>Protocol Number </td>
</tr>]"
398,CTRI/2020/11/029038,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
399,CTRI/2020/11/029058,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,No publication has been made from the current trial yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
400,CTRI/2020/11/029063,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None published yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Nil </td>
<td>NIL </td>
</tr>]"
401,CTRI/2020/11/029130,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Not Applicable,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
402,CTRI/2020/11/029146,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Nil </td>
<td>NIL </td>
</tr>]"
403,CTRI/2020/11/029170,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,None,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
404,CTRI/2020/11/029166,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,not applicable,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
405,CTRI/2020/11/029233,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
406,CTRI/2020/11/029232,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NA,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
407,CTRI/2020/11/029230,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NA,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
408,CTRI/2020/11/029263,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,None yet,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>GPL/CT/2020/007/IV Version 2.0 dated 26-Jun-20  </td>
<td>Protocol Number </td>
</tr>]"
409,CTRI/2020/11/029265,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Open to Recruitment,Not Applicable,Not yet; to be published later,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>U1111-1259-4250 </td>
<td>UTN </td>
</tr>]"
410,CTRI/2020/11/029289,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Nil,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>Nil </td>
<td>NIL </td>
</tr>]"
411,CTRI/2020/11/029305,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,Study will be published for academic purpose,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
412,CTRI/2020/11/029328,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NA,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>IND02-ORAL-COVID-19 Version 1.0 dated 15 Sep 2020 </td>
<td>Protocol Number </td>
</tr>]"
413,CTRI/2020/11/029356,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
414,CTRI/2020/11/029346,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NOT YET PUBLISHED ANYWHERE,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
415,CTRI/2020/11/029345,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Open to Recruitment,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>GCO 20 2115 </td>
<td>Protocol Number </td>
</tr>, <tr>
<td>NCT04512079 </td>
<td>ClinicalTrials.gov </td>
</tr>]"
416,CTRI/2020/11/029396,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
417,CTRI/2020/11/029399,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>NIL </td>
<td>NIL </td>
</tr>]"
418,CTRI/2020/11/029388,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>PIR/OBS/2020; Version No.: 4.0, Dated: 03/11/2020 </td>
<td>Protocol Number </td>
</tr>]"
419,CTRI/2020/11/029444,Applicable only for Completed/Terminated trials,Applicable only for Completed/Terminated trials,Not Yet Recruiting,Not Applicable,NIL,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID </b></font></td>
<td><font color=""white""><b>Identifier </b></font></td>
</tr>, <tr>
<td>SVACRC/20/1 V 2.0 Dated 09-Oct-2020 </td>
<td>NIL </td>
</tr>]"
